Keyphrases
Hematopoietic Stem Cell Transplantation
100%
Pediatric Hematopoietic Stem Cell Transplantation
59%
Graft-versus-host Disease (GvHD)
57%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
41%
Single-center Experience
37%
COVID-19
35%
Thalassemia
28%
Marrow Transplantation
28%
Supportive Care
28%
European Society
28%
Working Party
28%
Pediatric Diseases
28%
β-Thalassemia (β-thal)
25%
Pediatric Patients
21%
T Cells
20%
Turkey
19%
Efficacy Analysis
18%
Safety Analysis
18%
Gamma Irradiation
18%
Vaccine Candidate
18%
Severe Combined Immunodeficiency
18%
Laboratory Factors
18%
Infectious Diseases
18%
Synovial Sarcoma
18%
Clinical Factors
18%
Chimeric Antigen Receptor T Cells (CAR-T)
18%
Extramedullary
18%
Tacrolimus
18%
Cyclosporine
18%
Risk Factors
18%
Conditioning Regimen
16%
Free Survival
15%
Chemotherapy
15%
Gene mutation
15%
Pretransplant
14%
Post-transplantation Cyclophosphamide (PTCy)
14%
Working Diagnosis
14%
Pediatric
13%
Haplo-hematopoietic Stem Cell Transplantation
13%
Transplantation
12%
Clinical Outcomes
12%
SARS-CoV-2 Virus
12%
SARS-CoV-2 Vaccine
12%
Haploidentical
12%
B Cells
11%
Cytomegalovirus Infection
10%
Adverse Effects
10%
Inborn Errors of Immunity
10%
Bronchiolitis Obliterans
10%
Acute Lymphoblastic Leukemia
10%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
94%
Infection
33%
Allogeneic Hematopoietic Stem Cell Transplantation
32%
Supportive Care
28%
Pediatric Disease
28%
Thalassemia
28%
Transplantation
27%
Diseases
26%
COVID-19
21%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Bone Marrow Transplantation
18%
Synovial Sarcoma
18%
Tacrolimus
18%
Cyclosporine
18%
Lymphocyte
18%
T Cell
18%
Adolescence
15%
Thalassemia Major
15%
Graft Versus Host Reaction
14%
Chimeric Antigen Receptor
13%
Acute Lymphoblastic Leukemia
12%
Non-Hodgkin Lymphoma
12%
In Vitro
11%
Chimeric Antigen Receptor T-Cell
11%
Conditioning
11%
B Cell
10%
Neoplasm
10%
Cyclophosphamide
9%
Heart Function
9%
Ganglioneuroblastoma
9%
Haploidentical Transplantation
9%
Lymphoproliferative Disease
9%
CD40 Ligand
9%
Adrenoleukodystrophy
9%
Otitis Media
9%
Lateral Sinus Thrombosis
9%
Mesenchymal Stem Cell
9%
Blood Clotting Factor 8
9%
Haemophilia A
9%
Perceived Social Support
9%
Cytomegalovirus Infection
9%
Epstein Barr Virus
9%
Mucormycosis
9%
Erythropoiesis
9%
Genetic Predisposition
9%
Diabetes in Adolescents
9%
Insulin Dependent Diabetes Mellitus
9%
Aplastic Anemia
9%
Cancer Susceptibility
9%
Whole Body Radiation
9%